Previous close | 0.0212 |
Open | 0.0217 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0207 - 0.0217 |
52-week range | 0.0202 - 0.5590 |
Volume | |
Avg. volume | 803,259 |
Market cap | 1.292M |
Beta (5Y monthly) | 2.21 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.2180 |
Earnings date | 02 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.32 |
Direct sales revenue of €1.183M in Q2 2022, up +59% compared to Q1 2022 Doubling of Sycamore and Hickory users Fully integrated production of SteriSpineTM technologies within the group Eragny-sur-Oise, Fleurieux sur l’Arbresle, France, July 7th, 2022 5:45pm CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, delivering the safest treatment for spinal fractures urgently treated, announces its half-ye
Safe Orthopaedics announces the installation of a second SORA unit in France and will accelerate the SORA program in the second quarter of 2022 Several dozen surgeries validate the SORA model,Installation of a second unit at the Saint Charles Clinic (Lyon),Scheduled acceleration of the program starting in the second quarter of 2022. Eragny-sur-Oise, France, May 12nd, 2022 08h45 CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing and marketing of single-use tech
Safe group announces its 2021 results and reiterates its 2022 objectives 2021 revenues of €4.6 million, up +24%. +18% gross margin improvement Operating income at pre-sanitary crisis level +19% net income improvement4 strategic axes recalled for 2022 Eragny-sur-Oise, France, May 2nd, 2022 08h45 CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, delivering the safest treatment for spinal fractures u